Our positivity rate of 29% in pT2-pT4 tumors is in the lower range of published data where PD-L1 positivity ranged from 9 to 88% in studies analyzing 10 to 936 pT2–4 carcinomas [26–29]. Here, CD274 is linked to carcinoma.